| Symbol | QNCX |
|---|---|
| Name | QUINCE THERAPEUTICS, INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) |
| Address | 611 GATEWAY BLVD,SUITE 273, SOUTH SAN FRANCISCO, California, 94080, United States |
| Telephone | +1 415 910-5717 |
| Fax | — |
| — | |
| Website | https://www.quincetx.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001662774 |
| Description | Quince Therapeutics, Inc., is a late-stage biotechnology company dedicated to unlocking the power of a patients own biology for the treatment of rare diseases. The companys Phase 3 lead asset, EryDex, is the first product in development that leverages its proprietary Autologous Intracellular Drug Encapsulation, or AIDE, technology platform, which is a novel drug/device combination that uses an automated process designed to encapsulate a drug into the patients own red blood cells. Additional info from NASDAQ: |
Quince Therapeutics Appoints Recognized Leaders in Pulmonary Medicine to Scientific Advisory Board
Read moreNew Form 8-K/A - Quince Therapeutics, Inc. <b>Filed:</b> 2026-06-26 <b>AccNo:</b> 0001193125-26-285572 <b>Size:</b> 147 KB <br />Item 3.03: Material Modifications to Rights of Security Holders
Read more(99% Neutral) QUINCE THERAPEUTICS, INC. (QNCX) Announces Executive Changes
Read moreLamond David 🟢 acquired 2.7K shares (1 derivative) of Quince Therapeutics, Inc. (QNCX) at $0.95 Transaction Date: Jun 11, 2026 | Filing ID: 000832
Read moreSenner Christopher J. 🟢 acquired 2.7K shares (1 derivative) of Quince Therapeutics, Inc. (QNCX) at $0.95 Transaction Date: Jun 11, 2026 | Filing ID: 000830
Read moreRoberts Brigette 🟢 acquired 16.7M shares (9 derivative) of Quince Therapeutics, Inc. (QNCX) at $0.84 ($11.8M) Transaction Date: May 18, 2026 | Filing ID: 000004
Read more(99% Neutral) QUINCE THERAPEUTICS, INC. (QNCX) Announces Regulatory Update
Read moreNew Form 3 - Quince Therapeutics, Inc. <b>Filed:</b> 2026-06-11 <b>AccNo:</b> 0001346566-26-000003 <b>Size:</b> 11 KB
Read moreNew Form D - Quince Therapeutics, Inc. <b>Filed:</b> 2026-06-11 <b>AccNo:</b> 0000912282-26-000811 <b>Size:</b> 11 KB
Read moreNew Form D - Quince Therapeutics, Inc. <b>Filed:</b> 2026-06-11 <b>AccNo:</b> 0000912282-26-000809 <b>Size:</b> 11 KB
Read more